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Abstract
Genome-wide association studies of birth weight have focused on fetal genetics, whereas relatively little is known about the
role of maternal genetic variation. We aimed to identify maternal genetic variants associated with birth weight that could
highlight potentially relevant maternal determinants of fetal growth. We meta-analysed data on up to 8.7 million SNPs in up
to 86 577 women of European descent from the Early Growth Genetics (EGG) Consortium and the UK Biobank. We used struc-
tural equation modelling (SEM) and analyses of mother–child pairs to quantify the separate maternal and fetal genetic effects.
Maternal SNPs at 10 loci (MTNR1B, HMGA2, SH2B3, KCNAB1, L3MBTL3, GCK, EBF1, TCF7L2, ACTL9, CYP3A7) were associated with
offspring birth weight at P<5108. In SEM analyses, at least 7 of the 10 associations were consistent with effects of the
maternal genotype acting via the intrauterine environment, rather than via effects of shared alleles with the fetus. Variants,
or correlated proxies, at many of the loci had been previously associated with adult traits, including fasting glucose (MTNR1B,
GCK and TCF7L2) and sex hormone levels (CYP3A7), and one (EBF1) with gestational duration. The identified associations indi-
cate that genetic effects on maternal glucose, cytochrome P450 activity and gestational duration, and potentially on maternal
blood pressure and immune function, are relevant for fetal growth. Further characterization of these associations in mecha-
nistic and causal analyses will enhance understanding of the potentially modifiable maternal determinants of fetal growth,
with the goal of reducing the morbidity and mortality associated with low and high birth weights.
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Introduction
Individuals with birth weights approaching the lower or upper
ends of the population distribution are more at risk of adverse
neonatal and later-life health outcomes and mortality than
those of average weight (1–5). The factors influencing birth
weight involve both maternal and fetal genetic contributions in
addition to the environment. Genome-wide association studies
(GWASs) testing for common variant effects on own birth weight
(‘fetal’ GWAS) have so far identified 60 robustly associated loci
(6–8). The influence of common maternal genetic variation on
offspring birth weight, beyond the effects of transmitted genetic
variation, is poorly understood. Studies estimating the variance
in birth weight explained by fetal or maternal genetic factors,
using data on twins (9,10), families (11) or mother–child pairs
with genome-wide common variant data (8,12), have consis-
tently estimated a distinct maternal genetic contribution, which
is smaller than the fetal genetic contribution, with estimates
ranging from 3% to 22% of the variance explained (relative to
24% to 69% for fetal genetics).
Maternal genotypes may influence key maternal pheno-
types, such as circulating levels of glucose and other metabolic
factors, which could cross the placenta and affect the growth of
the fetus. For example, women with hyperglycemia due to rare
heterozygous mutations in the GCK gene have babies who are
heavier at birth (provided the babies do not inherit the muta-
tion) due to intrauterine exposure to high maternal glucose lev-
els (13). Additionally, maternal genotypes may act upon other
maternal attributes, such as vascular function or placental
transfer of nutrients, which are also likely to influence fetal
growth. Such maternal environmental effects could in turn
influence fetal growth separately from the effects of any
growth-related genetic variants that are inherited by the fetus
directly from the mother (Fig. 1). Supporting evidence for such
effects from analyses of common genetic variants includes pos-
itive associations between maternal weighted allele scores for
body mass index (BMI) or fasting glucose and offspring birth
weight, and an inverse association between a maternal
weighted allele score for systolic blood pressure and offspring
birth weight (14).
The goal of the current study was to apply a GWAS approach
to identify maternal genetic variants associated with offspring
birth weight. This could potentially highlight novel pathways by
which the maternal genotype influences offspring birth weight
through the intra-uterine environment. We performed a meta-
analysis of GWASs of offspring birth weight using maternal
genotypes in up to 86 577 women of European descent from 25
studies, including 37 945 participants from studies collaborating
in the Early Growth Genetics (EGG) Consortium and 48 632
participants from the UK Biobank (Supplementary Material,
Fig. S1). We identified 10 loci, and showed, using a novel struc-
tural equation model and analyses in mother–child pairs, that
the majority of these were maternal effects that were independ-
ent of the fetal genotype.
Results
The basic characteristics of study participants in the EGG
Consortium discovery, EGG follow-up and UK Biobank GWAS
analyses are presented in Supplementary Material, Tables S1–S3,
respectively.
Maternal SNPs at 10 loci were associated with offspring
birth weight at P<5108
We identified 10 autosomal loci that were associated with off-
spring birth weight at P< 53 108 (Fig. 2, Table 1, Supplementary
Material, Figs S2 and S3 and Table S4). The linkage disequili-
brium (LD) score regression intercept (15) from the overall meta-
analysis was 1.009, so there was little change in the test statistics
after adjusting for this inflation. Three of these loci (KCNAB1,
EBF1 and CYP3A7) were identified in UK Biobank data only, and
the index SNPs were unavailable in the EGG Consortium data.
Consideration of results for proxy SNPs at these three loci from
the EGG meta-analysis is in the next section. For the index SNPs
at the other seven loci, we observed no strong evidence of heter-
ogeneity in allelic effects between the EGG Consortium and UK
Biobank components of the meta-analysis (Supplementary
Material, Fig. S4 and Table S4). The majority of the index SNPs
mapped to non-coding sequence and were not in strong LD with
any coding variants (r2< 0.95), but the index SNP in SH2B3,
rs3184504, is a non-synonymous coding variant (R262W).
Approximate conditional analysis (see Materials and Methods)
showed no evidence of secondary signals at any locus at
P< 53108. In combination, the 10 loci explained 1.4% [standard
error (SE)¼ 1.2%] of variance in birth weight, whereas the var-
iance in birth weight captured by all autosomal genotyped var-
iants on the UK Biobank array was considerably greater: 11.1%
(SE¼ 0.6%).
Birth weight-raising alleles at KCNAB1 and EBF1were
associated with longer gestational duration
The associations at KCNAB1, EBF1 and CYP3A7 resulted from
analysis of UK Biobank data only, and index SNPs were unavail-
able in the EGG Consortium meta-analysis (imputed to HapMap
Phase 2). To investigate further the evidence for association at
these loci, we identified proxy SNPs (r2¼ 1) for KCNAB1
(rs9872556) and EBF1 (rs2964484) that were available in HapMap
Phase 2 (no proxy SNP was available at r2> 0.5 at the CYP3A7
locus). Meta-analysis of the EGG Consortium and UK Biobank
data showed weaker evidence of association overall, with some
evidence of heterogeneity between the EGG meta-analysis and
UK Biobank (P¼ 0.008 and 0.007, respectively; Table 1,
Supplementary Material, Table S4 and Fig. S4). In the UK
Biobank, women reported the birth weight of their first child,
but not the duration of gestation. In contrast, analyses of birth
weight in all but one EGG study [Queensland Institute of
Medical Research (QIMR), n¼ 892] were adjusted for the duration
of gestation. It is therefore possible that the associations
observed with birth weight at KCNAB1 and EBF1 in the UK
Biobank reflect primary associations with gestational duration.
Look-ups of the index SNPs and HapMap 2 proxy SNPs in a
Figure 1. A schematic diagram illustrating that maternal genetic factors may
influence fetal growth indirectly through the intra-uterine environment, or
directly through inheritance by the fetus.
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published dataset of the top 10 000 associated SNPs from a
GWAS of gestational duration and preterm birth in 43 568
women (16) showed evidence of association at both EBF1
(P< 1012) and KCNAB1 (P< 103; Supplementary Material,
Table S5). The birth weight-raising alleles were associated with
longer gestational duration.
Five associated SNPs were independent of those
identified in previous fetal GWAS of birth weight
The index SNPs at four of the identified loci (SH2B3, KCNAB1,
TCF7L2 and CYP3A7), mapped >2 Mb away from, and were statisti-
cally independent of any index SNPs previously associated with
birth weight at P< 5x108 in a fetal GWAS (r2< 0.05) (8).
A summary of candidate genes at these four loci is presented in
Supplementary Material, Table S6 [corresponding information for
the other loci was reported in (8)]. At MTNR1B and HMGA2, the
same index SNP was associated with birth weight in the same
direction in both the current study and the previous fetal GWAS.
At the four remaining loci, the maternal GWAS index SNPs were
within 0.5 to 15 kb of previously reported fetal GWAS index SNPs
with very different strengths of pairwise LD between the maternal
and fetal GWAS index SNPs. At the EBF1 and ACTL9 loci, the mater-
nal and fetal GWAS index SNPs were in strong LD (r2¼ 0.95 and
0.99, respectively), and the directions of association were consis-
tent, suggesting that they were tagging the same causal variant. At
the L3MBTL3 locus, the maternal and fetal directions of association
were consistent, but the index SNPs were weakly correlated
Figure 2. Manhattan plot of associations between 8 723 755 maternal autosomal SNPs and 17 352 maternal X-chromosome SNPs (all MAF>1%) and offspring birth
weight from the meta-analysis of up to 86 577 women. SNP position across the chromosomes (x-axis) and results of association tests between maternal genotype and
offspring birth weight adjusted for sex and, where available, gestational duration (–log10 P-value; y-axis) are shown. The index maternal SNP from the current study
and all SNPs within 500 kb of that SNP are highlighted either in red, or in purple. Those in purple indicate loci at which the index maternal SNP from the current study
was within 500k of an index SNP associated previously with own birth weight (i.e. in a ‘fetal GWAS of birth weight’) at P<53 108 (8). SNPs within 500 kb of the 54 other
index SNPs previously identified in the fetal GWAS of birth weight are highlighted in green. The red, horizontal line indicates a P value of 53 108.
Table 1. Ten maternal genetic loci associated with offspring birth weight (P< 53 108) in a European ancestry meta-analysis of up to 86 577
women
Locus Lead SNP Chr Position (bp, b37) Alleles EAF EGGþUKBB meta-analysis
Effect/Other Effect (SE) P-value n
MTNR1B rs10830963 11 92708710 G/C 0.29 0.052 (0.006) 1.03 1019 71 341
HMGA2 rs1351394 12 66351826 T/C 0.49 0.034 (0.005) 1.43 1010 68 247
SH2B3 rs3184504 12 111884608 C/T 0.52 0.033 (0.005) 6.93 1010 68 249
KCNAB1a rs7629460 3 155829938 C/A 0.59 0.039 (0.007) 1.63 109 48 632
KCNAB1b rs9872556 3 155829855 T/C 0.57 0.029 (0.005) 8.13 108 68 253
L3MBTL3 rs9375694 6 130356608 G/A 0.31 0.035 (0.006) 2.13 109 68 223
GCK rs2971669 7 44231778 T/C 0.23 0.038 (0.007) 5.53 109 68 162
EBF1a rs12520982 5 157894747 T/C 0.74 0.041 (0.007) 9.93 109 48 632
EBF1b rs2964484 5 157897437 A/G 0.71 0.031 (0.006) 4.63 107 67 547
TCF7L2 rs7903146 10 114758349 T/C 0.30 0.034 (0.006) 1.23 108 68 253
ACTL9 rs2918299 19 8787273 C/T 0.83 0.041 (0.007) 2.23 108 67 603
CYP3A7a rs45446698 7 99332948 G/T 0.04 0.089 (0.016) 2.43 108 48 632
Effects were aligned to the birth weight-raising allele and are presented in SD units [1 SD of birth weight¼484 g (7)]. Chr, chromosome; bp, base pair; b37, build 37; EAF,
effect allele frequency.
aIndex SNPs available in UK Biobank only.
bResults for proxy SNPs (r2¼1) at KCNAB1 and EBF1 available in both UK Biobank and EGG (imputed to HapMap Phase 2) are shown below the index SNPs, with full
details in Supplementary Material, Table S4 (in both cases there was weak evidence of heterogeneity of effect size between EGG and UK Biobank, P<0.01). No proxy for
rs45446698 at CYP3A7 with r2>0.5 was available in HapMap Phase 2.
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(r2¼ 0.13), and conditional analyses in UK Biobank suggested
weakening of the association when the L3MBTL3 SNP identified in
the fetal GWAS was accounted for [unconditional effect
(SE)¼ 0.033 (0.007), P¼ 1.43106; conditional effect (SE)¼0.024
(0.008), P¼ 1.23 103; Supplementary Material, Table S7]. At the
GCK locus, the minor allele frequencies of the maternal and fetal
GWAS index SNPs were very different (0.23 and 0.009, respectively),
and in low pairwise LD (r2¼ 0.002). Analysis conditional on the
fetal GWAS index SNP in UK Biobank did not alter the association
at the maternal index SNP (Supplementary Material, Table S7),
suggesting that at GCK, the maternal association with birth weight
was distinct from the previously reported fetal association.
Structural equation modelling applied to UK Biobank
data suggested most associations were driven by the
maternal genotype
The partial overlap between associations identified in the cur-
rent study and those identified in the previous fetal GWAS of
birth weight (Fig. 2 and Supplementary Material, Fig. S2) illus-
trates the expected correlation between maternal and fetal gen-
otypes (r 0.5). The associations between maternal genotype
and birth weight identified here may represent indirect effects
of maternal genotype on birth weight acting via the maternal
intrauterine environment, or primary effects of the fetal geno-
type on birth weight that are captured (due to correlation) when
assaying the maternal genotype, or a mixture of maternal and
fetal effects. Analysis of UK Biobank data using structural equa-
tion modelling (SEM; n¼ 78 674 male and female unrelated par-
ticipants, of whom 33 238 individuals only reported their own
birth weight, 20 963 women only reported the birth weight of
their first child and 24 473 women reported their own birth
weight and that of their first child; see Materials and Methods
and Fig. 3) provided estimates of maternal effects adjusted
for fetal genotype, and vice versa, and suggested that the
associations at the majority of the loci were driven by
the maternal genotype (Fig. 4 and Supplementary Material,
Table S8). In particular, the adjusted maternal effects estimated
at seven of the loci (MTNR1B, KCNAB1, GCK, EBF1, TCF7L2, ACTL9
and CYP3A7) were separated from the adjusted fetal effect esti-
mates by at least 2 SEs. The only locus at which the point esti-
mate for the adjusted fetal effect was larger than that of
adjusted maternal effect was HMGA2, suggesting this associa-
tion was driven by the fetal genotype. Additional analyses
(i) adjusting for fetal genotype in up to 8705 mother–child pairs
and (ii) comparing the unadjusted maternal effect estimates
from the overall maternal GWAS (n¼up to 86 577) with those
from a published fetal GWAS (n¼ 143 677), provided supporting
evidence that the majority of the effects were maternally driven
(Supplementary Material, Fig. S5 and Tables S8 and S9).
Known associations at the identified loci highlighted
potentially relevant maternal traits including fasting
glucose, blood pressure, immune function and sex
hormone levels
Look-ups of index SNPs (n¼ 7 loci), or SNPs in close LD (n¼ 2 loci
at r2> 0.9; n¼ 1 at r2¼ 0.4), in available GWAS datasets for cardi-
ometabolic and growth-related traits revealed several associa-
tions at P< 5 108 (Supplementary Material, Table S10), and
further information on previously reported associations was
obtained from the NHGRI-EBI catalog of GWAS (see Materials
and Methods).
The maternal birth weight-associated variants at MTNR1B,
GCK and TCF7L2 loci are known to be associated with fasting glu-
cose and Type 2 diabetes susceptibility (17,18), with the glucose-
raising allele associated with higher offspring birth weight.
The C-allele of the missense variant, rs3184504, in SH2B3,
associated with higher birth weight in our study, has been asso-
ciated with multiple cardiovascular traits [lower SBP and DBP
Figure 3. Diagram of the SEM used to estimate the conditional fetal and maternal effects on birth weight for each of the genome-wide significant SNPs. The three
observed variables (in rectangles) are the birth weight of the individual (BW), the birth weight of their offspring (BWO) and the genotype of the individual (SNP). The
latent variables (in circles) are the genotype of the individual’s mother (GG) and the genotype of the individual’s first offspring (GO). The total variance of the latent gen-
otypes for the individual’s mother (GG) and offspring (GO) and for the observed SNP variable is set to U [i.e. variance (GG)¼U; variance (SNP)¼0.25Uþ 0.75U;
variance(GO)¼0.25 Uþ0.75U]. The m and f path coefficients refer to maternal and fetal effects, respectively. The residual error terms for the birth weight of the individ-
ual and their offspring are represented by e and eO, respectively, and we estimate the variance of both of these terms in the SEM. The covariance between residual
genetic and environmental sources of variation is given by q.
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(19,20), altered lipid levels and lower risk of coronary artery dis-
ease, CAD (21,22)], altered haematological traits (23–26), lower
risk of autoimmune diseases and autoimmune disorders (27–
32), lower kynurenine levels (33), higher risk of tonsillectomy
(34) and higher risk of colorectal and endometrial cancer (35).
The maternal birth weight-raising allele at ACTL9 was in LD
(r2¼ 1) with alleles of nearby variants associated with lower risk
of atopic dermatitis (36) and higher risk of tonsillectomy (34).
At the CYP3A7 locus, an SNP in LD (rs34670419, r2¼ 0.74) with
our identified variant, rs45446698, has been associated with lev-
els of the hormones, progesterone and dehydroepiandrosterone
sulphate (DHEAS) (37). The maternal birth weight-raising allele
was associated with lower hormone levels.
The index SNP, rs12520982, at EBF1 is in LD (r2¼ 1) with
rs2963463, recently associated with gestational duration and pre-
term birth (16). SNPs in weak LD (r2< 0.1) with EBF1 rs12520982
were previously associated with blood pressure traits (19,38,39),
and rs12520982 showed moderate evidence of association with
SBP (P¼ 13105) and DBP (P¼ 13103) in the UK Biobank data
(Supplementary Material, Table S10). There were no known prior
associations with the birth weight-associated variation at KCNAB1.
The variants at HMGA2 and L3MBTL3 have been associated
with adult height (40). At HMGA2, and possibly also at L3MBTL3,
the association with birth weight is through the fetal allele, not
the maternal allele, so these associations with adult height are
relevant for offspring, not mother. Associations at HMGA2 were
additionally observed with other growth and development phe-
notypes: infant length (41), infant head circumference (42) and
primary or permanent tooth eruption (43,44).
To identify biological pathways underlying maternal regulation
of birth weight, we performed gene-set enrichment analysis using
Meta-Analysis Gene-set EnrichmeNT of variant Associations
(MAGENTA) (45). Seven pathways reached false discovery rate
(FDR)< 0.05, including three involved in the metabolism of xenobi-
otics (Supplementary Material, Table S11).
Discussion
In this study, we have identified variants in the maternal
genome at 10 loci that are robustly associated with offspring
birth weight. Five of the identified associations are independent
of those reported in previous fetal GWAS of birth weight (8),
bringing the total of known independent common variant asso-
ciations with birth weight to 65. Because maternal and fetal
genotype are correlated (r¼ 0.5), loci identified in GWAS of birth
weight to date could either represent effects of the maternal
genotype, acting via the intrauterine environment, or direct
effects of the fetal genotype, or a mixture of the two (Fig. 1). Our
analyses, and those of 58 previously reported loci (46), suggest
that although the majority of the 65 known associations indi-
cate direct effects of the fetal genotype, at least 7 associations
from the current study [those at MTNR1B, EBF1, ACTL9, KCNAB1,
GCK, TCF7L2 and CYP3A7, of which the first 3 were initially iden-
tified in fetal GWAS (8)] indicate maternal intrauterine effects.
The index SNP, rs45446698, at the CYP3A7 locus, is an
expression quantitative trait locus (eQTL) for CYP3A7 in adrenal
gland tissue (47). The CYP3A7 gene is part of the cytochrome
P450 family 3 subfamily A gene cluster, which encodes enzymes
responsible for the metabolism of multiple and diverse endoge-
nous and exogenous molecules (48), and SNP rs45446698 tags a
haplotype of seven highly correlated variants in the CYP3A7
promoter, known as the CYP3A7*1C allele (49,50). The CYP3A7
gene is predominantly expressed in fetal development, but
CYP3A7*1C results in expression in adult carriers (50,51). The
CYP3A7*1C allele, and correlated SNPs, have been associated
with circulating levels of DHEAS, progesterone and 2-hydroxyla-
tion pathway estrogen metabolites (37,52,53). There were no
associations between offspring birth weight and maternal SNPs
at each of nine loci (independent of CYP3A7) that are also
known to influence levels of DHEAS or progesterone (37,54)
(data not shown), suggesting that neither DHEAS nor progester-
one levels per se are likely to explain the association with birth
weight. Because CYP3A enzymes metabolize a diverse range of
substrates, there are many possible mechanisms by which
maternal CYP3A7*1C might be associated with birth weight. In
our conditional analysis, we observed weak evidence of an inde-
pendent association with the fetal allele at this locus in the
opposite direction to that of the maternal allele. Further analy-
ses in larger samples will be required to confirm this and to
investigate possible mechanisms underlying this association.
However, the association at this locus, together with the results
of the gene-set enrichment analysis, which highlighted path-
ways involved in xenobiotic metabolism, suggests that it is a
key avenue for future research into fetal outcomes.
The birth weight-raising maternal alleles at the identified loci
(MTNR1B, GCK and TCF7L2) are strongly associated with higher
fasting glucose and Type 2 diabetes in non-pregnant adults
(17,18), and with glycemic traits and gestational diabetes mellitus
in pregnant women (55–57). The association between raised
maternal glucose and higher offspring birth weight is the result
of higher fetal insulin secretion in response to increased placen-
tal transfer of glucose (58). Our results confirm previous maternal
candidate gene associations with birth weight at TCF7L2 and GCK
(55,59,60) and demonstrate the key role of maternal glucose levels
in influencing offspring birth weight (14,61). Notably, the Type 2
diabetes risk allele at each of these three loci was not associated
with birth weight independently of the maternal allele when
present in the fetus. This is contrary to what has been seen at
other Type 2 diabetes loci such as ADCY5 and CDKAL1, where risk
alleles in the fetus were associated with lower birth weight (8).
Figure 4. Independent maternal and fetal effects on birth weight at the 10 identi-
fied loci, estimated from a meta-analysis of results using an SEM in unrelated
UK Biobank participants with results using conditional analysis in maternal–
fetal pairs. All SNPs are aligned to the birth weight-raising allele reported in
Table 1. The colour of each dot indicates the maternal genetic association
P-value for birth weight, adjusted for the fetal genetic association: red,
P<0.0001; orange, 0.0001 P<0.001; yellow, 0.001P<0.05.
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However, there is an additional low-frequency fetal variant at the
GCK locus, which is independent of the glucose-raising maternal
variant associated with higher birth weight in the current study
(8). Taken together with the known effects on birth weight of
both maternal and fetal rare heterozygous GCK mutations (13), a
complex picture of allelic variation relevant to fetal growth is
emerging at this locus.
The association with birth weight at HMGA2 was previously
identified in a fetal GWAS of birth weight (same index SNP) (8),
and our analyses showed that the maternal SNP in our study
was probably capturing a direct effect of the SNP in the fetus on
skeletal growth, given previous associations with infant length,
head circumference and adult height (40–42). The L3MBTL3 locus
identified in our study is also a known height locus, and the
associated variant was correlated (r2¼ 0.13) with an SNP associ-
ated with birth weight in the previous fetal GWAS (8). It was less
clear from our analyses whether the association at L3MBTL3 ori-
ginated from the maternal or fetal genotype. However, analyses
of maternal height alleles transmitted to offspring versus those
not transmitted to offspring suggest that the majority of the
association between maternal height and offspring birth weight
are due to direct effects of fetal inherited alleles (62).
Our exploration of known associations at the remaining four
loci indicated a number of potentially relevant maternal traits that
could influence birth weight via the intrauterine environment,
including higher blood pressure (associations at SH2B3 and sug-
gestive associations at EBF1, both between the blood pressure rais-
ing maternal allele and lower offspring birth weight), which has
been causally associated with lower birth weight in Mendelian
randomization analyses (14), and immune function (associations
at SH2B3 and ACTL9). However, further studies are needed to eluci-
date the mechanisms at these loci and at KCNAB1, which showed
no previous associations with other traits.
We observed weak evidence of heterogeneity of effect sizes
between the EGG Consortium and UK Biobank components of
our meta-analysis at the KCNAB1 and EBF1 loci, which led us to
investigate possible explanations. A key difference was that
birth weight was adjusted for duration of gestation in the
majority of EGG studies, whereas the duration of gestation was
unavailable in the UK Biobank. This raised the possibility that
birth weight associations at KCNAB1 and EBF1 might arise from
a primary effect on gestational duration, i.e. these loci could be
primarily influencing the timing of delivery, rather than fetal
growth. It is of course possible that the heterogeneity indicated
false positive associations in the UK Biobank dataset that were
not replicated in the EGG dataset. However, directionally consis-
tent evidence of association with gestational duration and pre-
term birth in a recently published GWAS (P< 53108 at EBF1;
P< 103 at KCNAB1) suggests that this is unlikely.
There were some limitations to our study. First, the birth
weight of first child was self-reported by mothers in the UK
Biobank study, and so was likely subject to more error variation
and potential bias than measured birth weight. However,
maternal reports of offspring birth weight have been shown to
be accurate (63,64), and we showed that the birth weight of first
child variable was associated with maternal smoking, height,
BMI and socio-economic position in the expected directions.
A second limitation of our study was that by performing a
maternal GWAS of birth weight that does not account for the
fetal genotype, the analysis was biased against identifying
loci at which the fetal genotype exerts opposing effects.
Proof-of-principle that such loci exist is demonstrated by the
effects on birth weight of rare mutations in the GCK gene, which
act in opposite directions when present in either mother or
fetus, but result in normal birth weight if both mother and fetus
inherit the mutation (13). Our analysis conditional on fetal geno-
type at the 10 loci using a novel method (46) had greatly
increased power to resolve maternal versus fetal effects com-
pared with previous analyses in limited numbers of mother–
child pairs (8). Although it is not yet computationally feasible to
run such an analysis genome-wide, future studies will benefit
from considering maternal and fetal genotype simultaneously at
the discovery stage and are thereby likely to uncover further loci.
In conclusion, we have identified 10 maternal genetic loci asso-
ciated with offspring birth weight, 5 of which were not previously
identified in fetal GWAS of birth weight, and at least 7 of which
represent maternal intrauterine effects. Collectively, the identified
associations highlight key roles for maternal glucose and cyto-
chrome P450 activity and potential roles for maternal blood pres-
sure and immune function. Future genetic, mechanistic and
causal analyses will be required to characterize such intrauterine
effects, leading to greater understanding of the maternal determi-
nants of fetal growth, with the goal of reducing the morbidity and
mortality associated with low and high birth weights.
Materials and Methods
EGG Consortium discovery studies: genotyping,
imputation and GWAS analysis
We studied 19 626 unrelated women of European ancestry from
11 studies with maternal genome-wide genotypes and offspring
birth weight available. These included two sub-samples from
the 1958 British birth cohort [1958BC-WTCCC2 (65), n¼ 836;
1958BC-T1DGC (27), n¼ 858]; the Avon Longitudinal Study of
Parents and Children (ALSPAC, n¼ 7304) (66); a sub-sample of
the Danish National Birth Cohort from the Genetics of Extreme
Overweight in Young Adults study (DNBC-GOYA, n¼ 1805) (67);
population-based controls from a case–control study of pre-
term birth in the DNBC (DNBC-PTBCTRLS, n¼ 1656) (68); the
Hyperglycemia and Adverse Pregnancy Outcome study (HAPO,
n¼ 1280) (56); the Norwegian Mother and Child cohort study
(MoBa, n¼ 650) (69); the Northern Finland 1966 Birth Cohort
study (NFBC1966, n¼ 2035) (70); the Netherlands Twin Register
(n¼ 707) (71); the QIMR study of adult twins (n¼ 892) (72); the
Twins UK study (TwinsUK, n¼ 1603) (73).
Genotypes in each study were obtained through high-density
SNP arrays and up to 2.5 million autosomal SNPs were imputed
to HapMap Phase II. Study protocol was approved at each study
centre by the local ethics committee and written informed con-
sent had been obtained from all participants and/or their
parent(s) or legal guardians. Study descriptions and basic charac-
teristics of samples in the discovery phase are presented in
Supplementary Material, Table S1.
Within each study, we converted offspring birth weight (BW,
g) to a z-score [(BW value – mean(BW))/standard deviation(BW)]
to allow comparison of data across studies. We excluded multi-
ple births, stillbirths, congenital anomalies (where known) and
births before 37 weeks of gestation (where known). We assessed
the association between each SNP and offspring birth weight
using linear regression of the birth weight z-score against
maternal genotype (additive genetic model), with sex and gesta-
tional duration as covariables (gestational duration was
unavailable in the QIMR study, which contributed 4.5% of EGG
participants). Ancestry principal components were included as
covariables where necessary in the individual studies. Genome-
wide association analyses were conducted using PLINK (74),
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SNPTEST (75), Mach2qtl (76) or Beagle (77) (see Supplementary
Material, Table S1).
Genome-wide meta-analysis of 11 EGG Consortium
discovery studies
Before meta-analysis, SNPs with a minor allele frequency
(MAF)< 0.01 and poorly imputed SNPs [info< 0.8 (PLINK),
r2hat< 0.3 (MACH or Beagle) or proper_info< 0.4 (SNPTEST)]
were excluded. To adjust for inflation in test statistics generated
in each cohort, genomic control (78) was applied once to each
individual study (see Supplementary Material, Table S1 for k val-
ues in each study). Data annotation, exchange and storage were
facilitated by the SIMBioMS platform (79). Quality control of
individual study results and fixed-effects inverse variance
meta-analyses were undertaken by two meta-analysts in paral-
lel at different study centres using the software package METAL
(2009–10-10 release) (80). We obtained association statistics for a
total of 2 422 657 SNPs in the meta-analysis for which at least 7
of the 11 studies were included. The genomic control inflation
factor, k, in the overall meta-analysis was 1.007.
Follow-up of 18 SNPs in 13 additional EGG Consortium
studies
We selected 15 SNPs that surpassed a P-value threshold of
P< 13105 for follow-up in additional, independent studies. Of
these, one SNP (rs11020124) was in LD (r2¼ 0.63, 1000 Genomes
Pilot 1 data) with SNP rs10830963 at the MTNR1B locus known to
be associated with fasting glucose and Type 2 diabetes (81). We
assumed that these represented the same association signal.
Given its robust association with maternal glycemic traits likely
to impact on offspring birth weight, we took only rs10830963 for-
ward for follow-up at this locus. We identified three further SNPs
at loci with robust evidence (P< 53108) of association with
other phenotypes, and therefore higher prior odds of association
with birth weight: rs2971669 near GCK (r2¼ 0.73 with rs4607517
associated with fasting glucose) (60); rs204928 in LMO1 (r2¼ 0.90
with rs110419 associated with neuroblastoma) (82) and
rs7972086 in RAD51AP1 (r2¼ 0.27 with rs2970818 associated with
serum phosphorus concentration) (83). We took forward SNPs
rs4607517, rs204928 and rs7972086 for follow-up at these loci,
giving a total of 18 SNPs to be examined in additional studies.
The descriptions, genotyping details and basic phenotypic
characteristics of the follow-up studies are presented in
Supplementary Material, Table S2. Of a total of 13 follow up stud-
ies (n¼ 18 319 individuals), 9 studies (n¼ 15 288) provided custom
genotyping of between 4 and 18 SNPs, whereas 4 studies (n¼ 3031
individuals) had in silico genome-wide or exome-wide SNP geno-
types available. Where SNPs were imputed, we included only
those with quality scores (r2hat or proper_info) >0.8. We excluded
directly genotyped SNPs showing evidence of deviation from
Hardy–Weinberg Equilibrium at P< 0.0028 (Bonferroni corrected
for 18 tests). Where genotypes were unavailable for the index SNP,
we used r2> 0.8 proxies (see Supplementary Material, Table S12).
Preparation, quality control and genetic analysis in UK
Biobank samples
UK Biobank data were available for 502 655 participants, of
whom 273 463 were women (84), and of these women, 216 811
reported the birth weight of their first child (in pounds) either at
the baseline or follow-up assessment visit. We converted
pounds to kg (multiplying by 0.45) for use in our analyses. No
information was available on gestational duration or offspring
sex. A total of n¼ 64 072 women with offspring birth weight data
available also had genotype data available in the May 2015 data
release. Women identified as not of British descent (n¼ 9681)
were excluded from the analysis along with those reporting off-
spring birth weights of <2.5 or > 4.5 kg (n¼ 5479). ‘British
descent’ was defined as individuals who both self-identified as
white British and were confirmed as ancestrally Caucasian
using principal components analyses (http://biobank.ctsu.ox.ac.
uk; date last accessed August 2, 2017). A total of 1976 of the
women were asked to repeat the questionnaire at a follow-up
assessment and therefore had two reports of birth weight of
first child. Those with values differing by 1 lb (0.45 kg) were
excluded (n¼ 280). This resulted in n¼ 48 632 women with both
genotype data and a valid offspring birth weight value, which
was z-score transformed for analysis (Supplementary Material,
Table S3). UK Biobank carried out stringent quality control of
the GWAS genotype scaffold prior to imputation up to a refer-
ence panel of a combined 1000 Genomes Project Consortium
and UK10K Project Consortium. We tested for association with
birth weight of first child using a linear mixed model imple-
mented in BOLT-LMM (85) to account for cryptic population
structure and relatedness. Genotyping array was included as a
binary covariate in the regression model. Total chip heritability
(i.e. the variance explained by all autosomal polymorphic geno-
typed SNPs passing quality control) was calculated using
restricted maximum likelihood implemented in BOLT-LMM (85).
We additionally analysed the association between birth weight
of first child and directly genotyped SNPs on the X chromosome
in 45 445 unrelated women identified by UK Biobank as white
British. We excluded SNPs with evidence of deviation from
Hardy–Weinberg equilibrium (P< 13106), MAF< 0.01 or overall
missing rate> 0.015, resulting in 17 352 SNPs for analysis in
PLINK v.1.07, with the first 5 ancestry principal components as
covariates.
In both the full UK Biobank sample and our refined sample,
birth weight of first child was associated with mother’s smoking
status, maternal BMI and maternal height in the expected direc-
tions (Supplementary Material, Table S3).
Overall meta-analysis of discovery and follow-up
samples
A flowchart of the overall study design is presented in
Supplementary Material, Figure S1. We performed inverse var-
iance, fixed-effects meta-analysis of the association between
each SNP and birth weight z-score in up to 25 discovery and
follow-up studies combined (maximum total n¼ 86 577 women;
8 723 755 SNPs with MAF 0.01 plus 17 352 X-chromosome SNPs
in 45 445 women) using METAL (80). To check for population
substructure or relatedness that was not adequately accounted
for in the analysis, we examined the intercept value from uni-
variate LD score regression (15).
Approximate conditional analysis
At each of the identified loci, we looked for the presence of mul-
tiple distinct association signals in the region 1 Mb up- and
down-stream from the lead SNP through approximate condi-
tional analysis. Conditional and joint analysis in the analysis
program, genome-wide complex trait analysis (86) was applied
to identify secondary signals that attained genome-wide
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significance (P< 53 108) using a sample of 10 000 individuals
selected at random from the UK Biobank to approximate pat-
terns of LD between variants in these regions.
Candidate gene search
To search for candidate genes at the four loci not already cov-
ered by the previous fetal GWAS of birth weight (8), we identi-
fied the nearest gene, searched PubMed for relevant
information on genes within 300 kb of the index SNP, and
queried the index SNP for eQTL or proxy SNPs (r2> 0.8) reported
from GTEx v4, GEUVADIS, and 11 other studies using Haploreg
v4.1 (http://archive.broadinstitute.org/mammals/haploreg/hap
loreg.php; date last accessed August 2, 2017).
Estimating maternal and fetal genetic effects at the
identified loci
Because of the small number of cohorts with both maternal and
offspring genotype data available to conduct conditional analy-
sis, we developed a novel method using SEM to estimate the
conditional maternal and fetal genetic effects on birth weight,
which we subsequently applied to the maternal and offspring
birth weight data in the UK Biobank. SEM is a flexible multivari-
able statistical approach that allows investigators to model the
covariance between an observed set of variables (i.e. here an
individual’s genotype, their birth weight and their offspring’s
birth weight) as a function of several latent unobserved varia-
bles (i.e. here the genotype of the individual’s mother and the
genotype of their offspring). The full details of the SEM method
for estimating the conditional fetal and maternal effects are
described elsewhere (46). Briefly, as seen in Figure 3, we fitted a
structural equation model to three observed variables from the
UK Biobank study; the participant’s own self-reported birth
weight, the birth weight of the first child reported by the women
and the genotype of the participants. Our model included two
latent variables; one for the individual’s mother (i.e. grand-
maternal genotype) and one for the genotype of the partic-
ipant’s offspring. We know these latent variables are correlated
on average 50% with the individual’s own genotype, hence the
path coefficient between each of the latent variables and the
observed genotype was set to 0.5. Our model also included
residual error terms for the participant’s own birth weight and
the birth weight of their first child, a covariance parameter to
quantify similarity between the error terms, and a variance
parameter to model variation in the observed genotype. Using
this model, we were able to simultaneously estimate the effect
of maternal and fetal genotypes on offspring birth weight.
To fit the SEM, we used OpenMx (87) in R (version 3.3.2) (88)
with the raw UK Biobank data, and the P-value for the fetal and
maternal paths was calculated using a Wald test. We fitted a sec-
ond SEM without the child and maternal path to conduct a
2 degree of freedom test for the effect of the SNP on birth weight.
Genotype data from the UK Biobank May 2015 release was
used for analysis. We included 57 711 participants who reported
their own birth weight and 45 436 women who reported the
birth weight of their first child, giving a total of 78 674 unique
individuals in the analysis (24 473 women had both their own
and their offspring’s birth weight). Individuals who were not of
‘British descent’ (as defined earlier), or were related to others in
the sample, or who were part of multiple births, were excluded.
The birth weight of offspring phenotype was prepared as
described earlier, whereas own birth weight was prepared as
described previously (8). The included sample was smaller than
that used previously to fit the same structural equation model
to a different set of SNPs in the UK Biobank (46), because of a
narrower definition of ethnicity and a slightly narrower off-
spring birth weight range. The narrower definitions were
chosen here to match closely the sample analysed in the main
GWAS of the current study. We adjusted the individuals’ own
birth weight for sex, and both birth weight measures for the 12
genetically determined principal components and genotyping
batch before creating z-scores for analysis.
We analysed up to 8705 mother–child pairs from 4 studies
with both maternal and fetal genotypes available [ALSPAC,
Exeter Family Study of Childhood Health, HAPO (non-GWAS)
and DNBC-PTBCTRLS]. We used linear regression to test the
association between birth weight z-score and maternal geno-
type conditional on fetal genotype and vice versa (also adjusting
analyses for sex and gestational duration). We combined the
results from the individual studies using inverse variance meta-
analysis with fixed effects. We performed a further meta-
analysis to combine the overall estimates with those from the
SEM using UK Biobank data.
Look-ups in published GWAS and NHGRI GWAS catalog
We looked up associations between the 10 identified loci and var-
ious anthropometric and cardiometabolic traits in available
GWAS result sets. The traits and sources are presented in
Supplementary Material, Table S10. Where the index SNPs at
KCNAB1, EBF1 and CYP3A7 were unavailable, we used proxies
(r2¼ 0.99, 1.00 and 0.41, respectively). Because GWAS summary
statistics for blood pressure were not publicly available, we used
the UK Biobank May 2015 genetic data release and tested associa-
tions between the SNPs and systolic and diastolic blood pressure
(SBP and DBP) in 127 968 and 127 776 British descent participants,
respectively. Two blood pressure readings were taken approxi-
mately 5 min apart using an automated Omron blood pressure
monitor. Two valid measurements were available for most partic-
ipants, and the average was taken. Individuals were excluded if
the two readings differed by more than 4.56 SD (1 SD was equal to
19.7 and 13.1 mmHg for SBP and DBP, respectively), and blood
pressure measurements more than 4.56 SD away from the mean
were excluded. We accounted for blood pressure medication use
by adding 15 mmHg to the SBP measure and 10 mmHg to the DBP
measure in those reporting regular use of any antihypertensive.
Blood pressure was adjusted for age, sex and centre location and
then inverse normalized before analysis.
We additionally queried the NHGRI-EBI catalog of published
GWAS (http://www.ebi.ac.uk/gwas/home, last accessed 2
August 2017) for associations P< 53108 between any addi-
tional traits or diseases and SNPs within 500 kb of, and in LD
with, the index SNP at each locus.
Gene set enrichment analysis
We used MAGENTA to test for pathway-based associations
using summary statistics from the overall meta-analysis (45).
The software mapped each gene to the SNP with the lowest P
value within a 110 kb upstream and 40 kb downstream window.
The P value (representing a gene score) was corrected for con-
founding factors such as gene size, SNP density and LD-related
properties in a regression model. Genes within the HLA-region
were excluded. Genes were then ranked by their adjusted gene
scores. The observed number of gene scores in a given pathway
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with a ranked score above a given threshold (95th and 75th per-
centiles) was calculated and this statistic was compared with
1 000 000 randomly permuted pathways of the same size. This
generated an empirical P value for each pathway, and we con-
sidered pathways reaching FDR< 0.05 to be of interest. The 3230
biological pathways tested were from the BIOCARTA, Gene
Ontology, Ingenuity, KEGG, PANTHER and REACTOME data-
bases, with a small number of additional custom pathway.
Supplementary Material
Supplementary Material is available at HMG online. Summary
statistics from the meta-analysis are available at http://egg-
consortium.org/.
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